Mount Sinai health system to roll out Microsoft Dragon copilot

AI-powered voice assistant will enhance clinical efficiency, reduce burnout, and improve patient experiences across the System

2025-11-05

(Press-News.org) The Mount Sinai Health System today announced that it will implement Microsoft Dragon Copilot, a new AI clinical assistant designed to streamline clinical documentation, surface critical information, and automate administrative tasks across care settings. The rollout marks a major milestone in Mount Sinai’s ongoing digital transformation and its commitment to using responsible artificial intelligence to support clinicians and deliver better outcomes for patients.

Built on a modern, secure, and scalable architecture purpose-built for healthcare, Dragon Copilot integrates advanced natural language, ambient listening, and generative AI capabilities to help clinicians document care seamlessly within the electronic health record (EHR). The result is more efficient workflows, reduced administrative burden, and more time for meaningful interactions between clinicians and patients.

“Mount Sinai’s adoption of Dragon Copilot, after a multi-vendor evaluation, represents a transformative step forward in how we use technology to support our clinicians and elevate the care experience,” said Lisa Stump, Executive Vice President, Chief Digital Information Officer at Mount Sinai Health System, and Dean of Information Technology at the Icahn School of Medicine at Mount Sinai. “By embedding this AI assistant into the clinical workflow, we’re reducing documentation fatigue, improving information flow, and freeing up our care teams to focus on what matters most — caring for patients. We are excited to work with Microsoft as an enterprise partner, and excited to be the first academic medical center to deploy Dragon Copilot to our care team, as we collaborate on this rapidly evolving technology.”

The technology’s unified voice and ambient capabilities allow physicians, nurses, and care teams to automate documentation and associated tasks through the natural conversation with patients, using ambient and generative AI capabilities — simplifying complex tasks and enhancing care coordination. Clinicians benefit from faster, more accurate documentation, while patients experience more engaged, present providers.

“Artificial intelligence is transforming how we deliver, teach, and advance medicine,” said Brendan G. Carr, MD, MA, MS, Chief Executive Officer of the Mount Sinai Health System and Professor and Kenneth L. Davis, MD, Distinguished Chair. “At Mount Sinai, we are harnessing this technology responsibly — not to replace human judgment, but to empower it. Dragon Copilot strengthens the partnership between our care team and technology, allowing us to deliver smarter, more connected, and more compassionate care.”

“Mount Sinai continues to set the standard for innovation in academic medicine, and its rollout of Dragon Copilot is a powerful example of how the organization is harnessing AI responsibly to transform healthcare at scale,” said Kenneth Harper, General Manager, Dragon product, Microsoft Health and Life Sciences. “By embedding ambient and generative intelligence directly into clinical workflows, we’re helping clinicians reclaim time, reduce burnout, and deliver more connected, compassionate care. This deployment reflects our shared commitment to harnessing AI to put the human back at the center of patient care — empowering care teams to focus on what matters most: their patients.”

The rollout has begun with select departments with plans to expand system-wide in 2026. Each phase will include robust training, feedback, and evaluation to ensure equitable, secure, and effective integration across all clinical environments.

Mount Sinai’s leadership in adopting Dragon Copilot underscores its broader digital strategy to use AI-driven tools that enhance clinician well-being, operational excellence, and patient outcomes — reaffirming its role as a national model for innovation in academic medicine.

For more Mount Sinai Health System artificial intelligence news, visit: https://icahn.mssm.edu/about/artificial-intelligence

About the Mount Sinai Health System

Mount Sinai Health System is one of the largest academic medical systems in the New York metro area, with 48,000 employees working across seven hospitals, more than 400 outpatient practices, more than 600 research and clinical labs, a school of nursing, and a leading school of medicine and graduate education. Mount Sinai advances health for all people, everywhere, by taking on the most complex health care challenges of our time—discovering and applying new scientific learning and knowledge; developing safer, more effective treatments; educating the next generation of medical leaders and innovators; and supporting local communities by delivering high-quality care to all who need it.

Through the integration of its hospitals, labs, and schools, Mount Sinai offers comprehensive health care solutions from birth through geriatrics, leveraging innovative approaches such as artificial intelligence and informatics while keeping patients’ medical and emotional needs at the center of all treatment. The Health System includes approximately 9,000 primary and specialty care physicians and 10 free-standing joint-venture centers throughout the five boroughs of New York City, Westchester, Long Island, and Florida. Hospitals within the System are consistently ranked by Newsweek’s® “The World’s Best Smart Hospitals, Best in State Hospitals, World Best Hospitals and Best Specialty Hospitals” and by U.S. News & World Report's® “Best Hospitals” and “Best Children’s Hospitals.” The Mount Sinai Hospital is on the U.S. News & World Report® “Best Hospitals” Honor Roll for 2025-2026.

For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Instagram, LinkedIn, X, and YouTube.

END

ELSE PRESS RELEASES FROM THIS DATE:

Scientists map how the brain develops – and how it resolves inflammation

2025-11-05

Researchers at Karolinska Institutet and Yale University have created a multidimensional, molecular map of how the mouse brain develops after birth and how it reacts to inflammation. The study, which is published in Nature, shows that some of the molecular programmes that govern brain development can be reactivated in the brain during inflammation. Brain development is a complex process involving, for example, the precise diversification and distribution of cells into distinct areas. The researchers behind the present study ...

Triggering cell death in metastatic melanoma may pave the way for new cancer treatments

2025-11-05

Key points: Metastatic melanoma cells that have spread to lymph nodes survive by relying on a protein called ferroptosis suppressor protein 1 (FSP1)—a finding that points to FSP1 inhibitors as a potentially effective treatment for cancer progression. The study illuminates how metastasizing cancer cells can adapt to survive in lymph nodes, suggesting that treatments can be tailored to exploit cancer’s unique weaknesses according to where it is located in the body. The study also highlights new ways to understand cancerous cell death using in vivo models of cancer metastasis. Boston, ...

A path to safer painkillers – revealed by freezing opioids and their protein receptors in motion

2025-11-05

Key findings: Scientists captured six high-resolution “snapshots” showing how opioids activate — and how antidotes like Narcan block — a key brain receptor that controls pain and addiction. The study provides the first view of Narcan’s lifesaving action at the molecular level. The discovery offers new avenues for developing painkillers that relieve pain without triggering addiction or dangerous side effects. Scientists have known for decades that opioids relieve pain by binding to molecular switches in the brain called mu-opioid (pronounced “mew-opioid”) ...

Reducing reliance on corticosteroids with rituximab: renewed hope for adult-onset patients with relapsing nephrotic syndrome

2025-11-05

Osaka, Japan – One monoclonal antibody, rituximab, can work wonders for the treatment of children with frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome. However, what about patients who developed nephrotic syndrome in adulthood? As this drug is not yet approved for use in adult-onset patients, researchers from Japan wanted to highlight the profound benefits that rituximab has in adult-onset patients with these challenging conditions. Nephrotic syndrome is a kidney disorder that causes the body to excrete too much protein in the urine. This condition can lead to edema, weight gain, and an increased risk of infections. ...

Psilocybin outside the clinic – public health challenges of increasing publicity, accessibility, and use

2025-11-05

About The Study: The expanding use of unregulated psilocybin mushrooms, combined with high variability in composition and common co-use with other substances, raises urgent public health concerns. Existing clinical data are insufficient to guide harm reduction or policy. There is a pressing need to pivot from controlled efficacy trials to real-world research on psilocybin use, including public education, potency testing, and age-specific risk assessment. Corresponding Author: To contact the corresponding author, Kent E. Hutchison, PhD, email kent.hutchison@cuanschutz.edu. To access the ...

Parent-teen sexual health communication and teens’ health information and service seeking

2025-11-05

About The Study: In a cross-sectional, nationally representative survey of 522 parent-teen dyads, frequent parent-teen sexual health communication was associated with increased teen self-efficacy for sexual and reproductive health information and service seeking, but this depended on how comfortable and informed their parents felt. These findings suggest that parents must possess accurate information and comfort to discuss sexual health topics. Corresponding Author: To contact the corresponding author, Hannah Javidi, PhD, email hjavidi@ncat.edu. To ...

Two small changes, that may transform agriculture

2025-11-05

"We are one step closer to a greener and climate-friendlier food production." That is the assessment from Kasper Røjkjær Andersen and Simona Radutoiu, both professors of molecular biology at Aarhus University. The two researchers led a new study where they discovered an important key to understanding how we can reduce agriculture’s need for artificial fertilizer. Plants need nitrogen to grow, a nutrient that most crops solely get from fertilizer. Only a few plants, such as peas, clover, and beans, can manage without it. They live in symbiosis ...

New brain atlas offers unprecedented detail in MRI scans

2025-11-05

A new AI-assisted brain atlas that can help visualise the human brain in unprecedented detail has been developed by UCL researchers, in a major step forward for neuroscience and neuroimaging. The human brain comprises hundreds of interconnected regions that drive our thoughts, emotions, and behaviours. Existing brain atlases can identify major structures in MRI scans – such as the hippocampus, which supports memory and learning – but their finer sub-regions remain hard to detect. These distinctions matter because sub-regions ...

Two main gene discovery methods reveal complementary aspects of biology

2025-11-05

The two main approaches for discovering disease genes reveal distinct aspects of biology, a new study shows. While both methods are widely used, the research found that they identify different genes, with major implications for drug development. Publishing online Nov. 5 in Nature, the study revolves around the human genome, which contains thousands of genes that provide instructions for making proteins, as well as regulatory DNA that controls when genes turn on. The new investigation takes a genome-wide ...

Blocking key protein triggers cancer cell self-destruction

2025-11-05

NYU Langone Health researchers found that a type of cell death caused by a buildup of highly reactive molecules suppresses lung tumor growth. The process, called ferroptosis, evolved to let the body signal for self-destruction of cells that are overly stressed for various reasons. This includes cancer cells, but they in turn evolved to have mechanisms that counter ferroptosis so they can continue their uncontrolled growth despite the stress it creates. Published online November 5 in Nature, the new study showed that an experimental treatment blocked the action in cancer ...

LAST 30 PRESS RELEASES:

How to identify and prevent fraudulent participants in health research

Parents' attachment style may be linked with risk of parental burnout, especially when associated with difficulty in understanding and identifying their emotions